Ketone Bodies Promote Amyloid-β(1–40) Clearance in a Human in Vitro Blood–Brain Barrier Model

Alzheimer’s disease (AD) is characterized by the abnormal accumulation of amyloid-β (Aβ) peptides in the brain. The pathological process has not yet been clarified, although dysfunctional transport of Aβ across the blood–brain barrier (BBB) appears to be integral to disease development. At present,...

Descripción completa

Detalles Bibliográficos
Autores principales: Versele, Romain, Corsi, Mariangela, Fuso, Andrea, Sevin, Emmanuel, Businaro, Rita, Gosselet, Fabien, Fenart, Laurence, Candela, Pietra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037612/
https://www.ncbi.nlm.nih.gov/pubmed/32023814
http://dx.doi.org/10.3390/ijms21030934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037612/
https://www.ncbi.nlm.nih.gov/pubmed/32023814
http://dx.doi.org/10.3390/ijms21030934

Ejemplares similares